Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype
Public ClinicalTrials.gov record NCT01459913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b Study of 2 Treatment Durations of Telaprevir, Peg-IFN (Pegasys®), and Ribavirin (Copegus®) in Treatment-Naive and Prior Relapser Subjects With Genotype 1 Chronic Hepatitis C and IL28B CC Genotype
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate if a 12-week total regimen of telaprevir in combination with pegylated interferon alfa 2a (Peg-IFN-alfa-2a) and ribavirin (RBV) (T12/PR12) is safe and effective in subjects who have the interleukin-28B (IL28B) CC genotype. The subjects enrolled in this study will have chronic hepatitis C virus (HCV) infection and will not have cirrhosis of the liver.
Study identification
- NCT ID
- NCT01459913
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Type not available)
- Primary completion
- Jan 2014 (Actual)
- Completion
- Jan 2014 (Actual)
- Last update posted
- Jun 10, 2015
2011 – 2014
United States locations
- U.S. sites
- 55
- U.S. states
- 21
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Phoenix | Arizona | 85054 | — |
| Not listed | La Jolla | California | 93037 | — |
| Not listed | Los Angeles | California | 90027 | — |
| California | Los Angeles | California | 90048 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92105 | — |
| Not listed | San Diego | California | 92154 | — |
| California | San Francisco | California | 94115 | — |
| Not listed | Farmington | Connecticut | 06030 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Bradenton | Florida | 34209 | — |
| Not listed | Gainesville | Florida | 32224 | — |
| Not listed | Jacksonville | Florida | 32224 | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Honolulu | Hawaii | 96817 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Baltimore | Maryland | 21202 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Columbia | Maryland | 21045 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Brockton | Massachusetts | 02302 | — |
| Not listed | Burlington | Massachusetts | 01805 | — |
| Not listed | Worcester | Massachusetts | 01605 | — |
| Not listed | Novi | Michigan | 48202 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | Lebanon | New Hampshire | 03756 | — |
| Not listed | Egg Harbor | New Jersey | 08234 | — |
| Not listed | Vineland | New Jersey | 08360 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | Manhasset | New York | 10030 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Charlotte | North Carolina | 28203 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Pennsylvania | Hershey | Pennsylvania | 17033 | — |
| Not listed | Arlington | Texas | 76012 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Virginia | Fairfax | Virginia | 22031 | — |
| Not listed | Falls Church | Virginia | 22042 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Richmond | Virginia | 23249 | — |
| Not listed | Seattle | Washington | 98101 | — |
| Not listed | Madison | Wisconsin | 53715 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01459913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01459913 live on ClinicalTrials.gov.